CERo Therapeutics Holdings Inc (NASDAQ:CERO) currently has a daily average trading volume of 716.15K but it saw 939533 shares traded in last market. With a market cap of 4.08M USD, the company’s current market price of $0.80 came rising about 5.49 while comparing to the previous closing price of $0.76. In past 52 weeks, the stock remained buoying in the range of price level as high as $171.00 and as low as $0.53. In the recent trading on the day, stock has struck highest price mark of $0.7628 while lowest mark touched by it was $0.8603.
Taking a look at 20-day trading activity of CERo Therapeutics Holdings Inc (CERO) gives us an average price of $0.7170, while its current price level is -99.53% below from 52-week high level whereas it is 49.76% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.1456 while that of 200 days or SMA-200 reads an average of $8.7286. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.01% during that period while stretching the period over a month that increases to 15.03%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 44.93 which implies that the stock is in neutral territory.
Over the week, CERO’s stock price is moving 36.65% up while it is -15.85% when we observe its performance for the past one month. Year-to-date it is -86.68% down and over the past year, the stock is showing a downside performance of -99.47%.
The company is expected to be releasing its next quarterly report in May, for which analysts forecasted an EPS of -5.96 while estimate for next year EPS is -7.29.
Currently, CERo Therapeutics Holdings Inc’s 15.91% of that held by the insiders while 6.59% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -11090.59% and return on equity (ROE) at -4090.08%. Stock’s beta reads 0.61. Its return on asset (ROA) is -103.40% on average.
